Justin B. Klee

Insider Reports History

Entity
Individual
Location
C/O Amylyx Pharmaceuticals, Inc., 43 Thorndike Street, Cambridge, MA
Signature
/s/ Joshua B. Cohen, as Attorney in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Justin B. Klee:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Amylyx Pharmaceuticals, Inc. Co-Chief Executive Officer, Director Common Stock 3.14M $58.8M $18.73 Apr 16, 2024 Direct
Amylyx Pharmaceuticals, Inc. Co-Chief Executive Officer, Director Stock Option (right to buy) 380K Apr 16, 2024 Direct

Insider Reports Filed by Justin B. Klee

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AMLX Amylyx Pharmaceuticals, Inc. Apr 16, 2024 2 $0 4 Apr 18, 2024 Co-Chief Executive Officer, Director
AMLX Amylyx Pharmaceuticals, Inc. Mar 5, 2024 1 -$77.4K 4 Mar 7, 2024 Co-Chief Executive Officer, Director
AMLX Amylyx Pharmaceuticals, Inc. Feb 26, 2024 2 $0 4 Feb 28, 2024 Co-Chief Executive Officer, Director
AMLX Amylyx Pharmaceuticals, Inc. Jan 9, 2024 1 -$95.4K 4 Jan 11, 2024 Co-Chief Executive Officer, Director
AMLX Amylyx Pharmaceuticals, Inc. Mar 16, 2023 4 -$3.19M 4 Mar 20, 2023 Co-Chief Executive Officer, Director
AMLX Amylyx Pharmaceuticals, Inc. Jan 6, 2023 2 $217K 4 Jan 10, 2023 Co-Chief Executive Officer, Director
AMLX Amylyx Pharmaceuticals, Inc. May 5, 2022 2 $124K 4 May 6, 2022 Co-Chief Executive Officer, Director
AMLX Amylyx Pharmaceuticals, Inc. Jan 6, 2022 4 $0 4 Jan 10, 2022 Co-Chief Executive Officer, Director
AMLX Amylyx Pharmaceuticals, Inc. Jan 6, 2022 0 $0 3 Jan 6, 2022 Co-Chief Executive Officer, Director